Patent · US Active

Compounds and their methods of use

US9303002B2 · kind B2 · utility

5Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2013
Grant dateApr 5, 2016
Priority date
Expiry dateNov 21, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.